Streetbeat News

Products Services

PTCT

PTC Therapeutics announced that the FDA has accepted its New Drug Application (NDA) for Sepiapterin, a treatment for both pediatric and adult patients with Phenylketonuria (PKU). This marks a significant step forward in the approval process for this potential new treatment.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 1:03 pm

CMTL

Comtech has received an initial order from SES Space & Defense for its SLM-5650B satellite modem. The financial terms of the deal were not disclosed.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 1:03 pm

AMZN

NVDA

TSLA

Tesla's stock surged over 24% in September, outperforming its Magnificent Seven peers. The upcoming Robotaxi event on October 10 is generating optimism, with potential updates on full self-driving and autonomous driving. Tesla's technical indicators remain bullish, but the stock may face resistance if key updates disappoint.

Portfolio Pulse from Surbhi Jain

October 01, 2024 | 12:55 pm

LLY

Eli Lilly plans to expand trials of its weight-loss drugs, Mounjaro and Zepbound, to individuals at risk of weight gain, not just those who are overweight. The company is considering lowering the BMI threshold for trials, which could broaden the market for its drugs. This move comes amid high demand and competition in the weight-loss drug market.

Portfolio Pulse from Benzinga Neuro

October 01, 2024 | 12:51 pm

CAMX

CME

IAI

CME Group Inc. is expanding its Nikkei 225 futures offerings by introducing yen- and U.S. dollar-denominated Micro Nikkei futures, pending regulatory approval. This move aims to enhance trading precision and efficiency in Japanese equity derivatives. The expansion reflects CME's strategy to provide more granular trading capabilities and mitigate FX exposure.

Portfolio Pulse from Lekha Gupta

October 01, 2024 | 12:45 pm

JAGX

Jaguar Health announced that their Phase 3 OnTarget trial for Crofelemer showed statistically significant results in a prespecified subgroup of adult breast cancer patients. This is a positive development for the company.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 12:39 pm

GDC

GD Culture Group Limited (NASDAQ:GDC) has partnered with Tuolan Network Technology Co. to expand its AI Creator Community. This partnership includes an AI Video Contest to encourage innovative AI-generated content, aiming to boost brand exposure and technology usage.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 12:37 pm

SIDU

Sidus Space has completed environmental testing for its LizzieSat-2 satellite, marking a critical milestone as it prepares for the satellite's launch into Low Earth Orbit later this year.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 12:36 pm

INSE

Inspired Entertainment has secured a licensing agreement with the NHL, allowing them to use NHL brand assets to create immersive gaming experiences. This will involve advanced motion capture technology for enhanced realism.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 12:36 pm

INBS

Intelligent Bio Solutions Inc. (NASDAQ:INBS) has secured GPS Marine as a new client for its fingerprint drug testing technology, enhancing workplace safety in maritime services.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 12:35 pm